Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells - PubMed (original) (raw)
. 1988 Dec 5;263(34):18220-4.
Affiliations
- PMID: 3142872
Free article
Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells
J Kuiper et al. J Biol Chem. 1988.
Free article
Abstract
The interaction in vivo of 125I-labeled tissue-type plasminogen activator (t-PA) with the rat liver and the various liver cell types was characterized. Intravenously injected 125I-t-PA was rapidly cleared from the plasma (t1/2 = 1 min), and 80% of the injected dose associated with the liver. After uptake, t-PA was rapidly degraded in the lysosomes. The interaction of 125I-t-PA with the liver could be inhibited by preinjection of the rats with ovalbumin or unlabeled t-PA. The intrahepatic recognition site(s) for t-PA were determined by subfractionation of the liver in parenchymal, endothelial, and Kupffer cells. It can be calculated that parenchymal cells are responsible for 54.5% of the interaction of t-PA with the liver, endothelial cells for 39.5%, and Kupffer cells for only 6%. The association of t-PA with parenchymal cells was not mediated by a carbohydrate-specific receptor and could only be inhibited by an excess of unlabeled t-PA, indicating involvement of a specific t-PA recognition site. The association of t-PA with endothelial cells could be inhibited 80% by the mannose-terminated glycoprotein ovalbumin, suggesting that the mannose receptor plays a major role in the recognition of t-PA by endothelial liver cells. An excess of unlabeled t-PA inhibited the association of 125I-t-PA to endothelial liver cells 95%, indicating that an additional specific t-PA recognition site may be responsible for 15% of the high affinity interaction of t-PA with this liver cell type. It is concluded that the uptake of t-PA by the liver is mainly mediated by two recognition systems: a specific t-PA site on parenchymal cells and the mannose receptor on endothelial liver cells. It is suggested that for the development of strategies to prolong the half-life of t-PA in the blood, the presence of both types of recognition systems has to be taken into account.
Similar articles
- Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.
Otter M, Kuiper J, Bos R, Rijken DC, van Berkel TJ. Otter M, et al. Biochem J. 1992 Jun 1;284 ( Pt 2)(Pt 2):545-50. doi: 10.1042/bj2840545. Biochem J. 1992. PMID: 1318035 Free PMC article. - In vivo and in vitro interaction of high and low molecular weight single-chain urokinase-type plasminogen activator with rat liver cells.
Kuiper J, Rijken DC, de Munk GA, van Berkel TJ. Kuiper J, et al. J Biol Chem. 1992 Jan 25;267(3):1589-95. J Biol Chem. 1992. PMID: 1730704 - Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells.
Rijken DC, Otter M, Kuiper J, van Berkel TJ. Rijken DC, et al. Thromb Res Suppl. 1990;10:63-71. doi: 10.1016/0049-3848(90)90379-q. Thromb Res Suppl. 1990. PMID: 2107599 Review. - Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator.
Tanswell P, Seifried E, Stang E, Krause J. Tanswell P, et al. Arzneimittelforschung. 1991 Dec;41(12):1310-9. Arzneimittelforschung. 1991. PMID: 1815534 Review.
Cited by
- The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator.
Babenko VA, Fedulova KS, Silachev DN, Rahimi-Moghaddam P, Kalyuzhnaya YN, Demyanenko SV, Plotnikov EY. Babenko VA, et al. J Pers Med. 2023 Jul 23;13(7):1175. doi: 10.3390/jpm13071175. J Pers Med. 2023. PMID: 37511788 Free PMC article. Review. - The multifaceted role of plasminogen in inflammation.
Heissig B, Salama Y, Takahashi S, Osada T, Hattori K. Heissig B, et al. Cell Signal. 2020 Nov;75:109761. doi: 10.1016/j.cellsig.2020.109761. Epub 2020 Aug 28. Cell Signal. 2020. PMID: 32861744 Free PMC article. Review. - Low Density Receptor-Related Protein 1 Interactions With the Extracellular Matrix: More Than Meets the Eye.
Bres EE, Faissner A. Bres EE, et al. Front Cell Dev Biol. 2019 Mar 15;7:31. doi: 10.3389/fcell.2019.00031. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 30931303 Free PMC article. Review. - The role of endogenous tissue-type plasminogen activator in neuronal survival after ischemic stroke: friend or foe?
Zhu J, Wan Y, Xu H, Wu Y, Hu B, Jin H. Zhu J, et al. Cell Mol Life Sci. 2019 Apr;76(8):1489-1506. doi: 10.1007/s00018-019-03005-8. Epub 2019 Jan 17. Cell Mol Life Sci. 2019. PMID: 30656378 Free PMC article. Review. - Carbohydrate analysis throughout the development of a protein therapeutic.
Higgins E. Higgins E. Glycoconj J. 2010 Feb;27(2):211-25. doi: 10.1007/s10719-009-9261-x. Epub 2009 Nov 4. Glycoconj J. 2010. PMID: 19888650 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources